Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Document And Entity Information

Document And Entity Information - USD ($)
12 Months Ended
Nov. 30, 2019
Feb. 28, 2020
Feb. 25, 2020
Document and Entity Information [Abstract]      
Entity Registrant Name Intellipharmaceutics International Inc.    
Document Type 20-F    
Current Fiscal Year End Date --11-30    
Entity Common Stock, Shares Outstanding     0
Entity Public Float   $ 0  
Amendment Flag false    
Entity Central Index Key 0001474835    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Well-known Seasoned Issuer No    
Document Period End Date Nov. 30, 2019    
Document Fiscal Year Focus 2019    
Document Fiscal Period Focus FY    
Entity Interactive Data Current Yes    
Entity Incorporation State Country Code A6